Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 11 | 2025 | 408 | 5.240 |
Why?
|
| Hemostatics | 5 | 2023 | 52 | 3.790 |
Why?
|
| Blood Preservation | 9 | 2025 | 285 | 3.750 |
Why?
|
| Hemostasis | 6 | 2024 | 82 | 2.270 |
Why?
|
| Platelet Transfusion | 4 | 2025 | 67 | 1.990 |
Why?
|
| Blood Donors | 3 | 2025 | 105 | 1.730 |
Why?
|
| Platelet Aggregation | 3 | 2025 | 103 | 1.700 |
Why?
|
| Blood Safety | 2 | 2021 | 11 | 1.330 |
Why?
|
| Hemorrhage | 7 | 2025 | 722 | 1.220 |
Why?
|
| Thrombin | 3 | 2023 | 152 | 1.100 |
Why?
|
| Wounds and Injuries | 6 | 2024 | 758 | 1.070 |
Why?
|
| Cryopreservation | 1 | 2025 | 100 | 0.890 |
Why?
|
| Fibrinogen | 2 | 2024 | 168 | 0.860 |
Why?
|
| Microfluidics | 1 | 2024 | 54 | 0.860 |
Why?
|
| Testosterone | 2 | 2024 | 409 | 0.840 |
Why?
|
| Hormone Replacement Therapy | 1 | 2024 | 100 | 0.820 |
Why?
|
| Factor VIII | 1 | 2021 | 98 | 0.680 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2019 | 26 | 0.610 |
Why?
|
| Blood Transfusion | 5 | 2023 | 325 | 0.580 |
Why?
|
| Cold Temperature | 4 | 2025 | 179 | 0.510 |
Why?
|
| Resuscitation | 3 | 2023 | 251 | 0.460 |
Why?
|
| Tranexamic Acid | 2 | 2022 | 40 | 0.350 |
Why?
|
| Blood Coagulation Disorders | 2 | 2024 | 173 | 0.340 |
Why?
|
| Plasma | 2 | 2021 | 212 | 0.290 |
Why?
|
| Humans | 24 | 2025 | 137585 | 0.270 |
Why?
|
| Erythrocytes | 2 | 2024 | 700 | 0.250 |
Why?
|
| Plateletpheresis | 2 | 2023 | 27 | 0.240 |
Why?
|
| Bleeding Time | 1 | 2024 | 7 | 0.220 |
Why?
|
| Erythrocyte Deformability | 1 | 2024 | 19 | 0.220 |
Why?
|
| von Willebrand Factor | 1 | 2024 | 80 | 0.220 |
Why?
|
| Purines | 1 | 2023 | 176 | 0.200 |
Why?
|
| Cell Count | 1 | 2023 | 324 | 0.190 |
Why?
|
| Blood Coagulation Tests | 1 | 2022 | 67 | 0.190 |
Why?
|
| Erythrocyte Transfusion | 1 | 2024 | 194 | 0.190 |
Why?
|
| Cell Separation | 1 | 2023 | 318 | 0.190 |
Why?
|
| Antifibrinolytic Agents | 1 | 2022 | 51 | 0.180 |
Why?
|
| Thromboembolism | 1 | 2022 | 119 | 0.180 |
Why?
|
| Sterilization | 1 | 2021 | 23 | 0.180 |
Why?
|
| Blood Coagulation Factors | 1 | 2021 | 54 | 0.170 |
Why?
|
| Heparin | 1 | 2022 | 261 | 0.170 |
Why?
|
| Central Venous Catheters | 1 | 2021 | 51 | 0.170 |
Why?
|
| Enoxaparin | 1 | 2021 | 63 | 0.170 |
Why?
|
| Lymphoid Tissue | 1 | 2020 | 75 | 0.160 |
Why?
|
| Shock | 1 | 2021 | 98 | 0.160 |
Why?
|
| Male | 9 | 2025 | 67762 | 0.160 |
Why?
|
| Blood Component Transfusion | 1 | 2020 | 84 | 0.160 |
Why?
|
| Catheterization, Central Venous | 1 | 2021 | 112 | 0.160 |
Why?
|
| Critical Illness | 2 | 2022 | 811 | 0.150 |
Why?
|
| Free Radical Scavengers | 1 | 2019 | 88 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 190 | 0.150 |
Why?
|
| Female | 8 | 2025 | 73304 | 0.150 |
Why?
|
| Animals | 7 | 2025 | 36940 | 0.150 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 139 | 0.150 |
Why?
|
| Cell-Derived Microparticles | 1 | 2019 | 71 | 0.140 |
Why?
|
| Thrombelastography | 1 | 2019 | 154 | 0.140 |
Why?
|
| Complement Pathway, Classical | 1 | 2017 | 20 | 0.140 |
Why?
|
| Oxidative Stress | 1 | 2024 | 1317 | 0.140 |
Why?
|
| HLA-A Antigens | 1 | 2017 | 55 | 0.140 |
Why?
|
| Shock, Hemorrhagic | 1 | 2019 | 167 | 0.130 |
Why?
|
| Tuberculosis | 1 | 2020 | 279 | 0.130 |
Why?
|
| Complement Inactivating Agents | 1 | 2017 | 63 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2024 | 3556 | 0.130 |
Why?
|
| Metabolome | 1 | 2019 | 350 | 0.130 |
Why?
|
| Aorta | 1 | 2019 | 417 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2021 | 664 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2017 | 466 | 0.120 |
Why?
|
| Phenotype | 1 | 2024 | 3196 | 0.120 |
Why?
|
| Adult | 5 | 2024 | 37929 | 0.120 |
Why?
|
| Endothelial Cells | 2 | 2019 | 785 | 0.120 |
Why?
|
| Monocytes | 1 | 2017 | 563 | 0.110 |
Why?
|
| Metabolomics | 1 | 2019 | 678 | 0.110 |
Why?
|
| Middle Aged | 3 | 2024 | 33479 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2022 | 7604 | 0.100 |
Why?
|
| Double-Blind Method | 3 | 2022 | 1993 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 890 | 0.090 |
Why?
|
| ABO Blood-Group System | 2 | 2023 | 51 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2022 | 11074 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1430 | 0.080 |
Why?
|
| Proportional Hazards Models | 2 | 2023 | 1266 | 0.070 |
Why?
|
| Child | 3 | 2022 | 21935 | 0.070 |
Why?
|
| Lung | 1 | 2020 | 4060 | 0.070 |
Why?
|
| Adolescent | 2 | 2022 | 21513 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 2074 | 0.050 |
Why?
|
| Hemolysis | 1 | 2024 | 206 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 1120 | 0.040 |
Why?
|
| L-Selectin | 1 | 2020 | 24 | 0.040 |
Why?
|
| Endothelium | 1 | 2021 | 123 | 0.040 |
Why?
|
| Trehalose | 1 | 2020 | 32 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2019 | 57 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 155 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2020 | 166 | 0.040 |
Why?
|
| Tissue Preservation | 1 | 2019 | 12 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2020 | 148 | 0.040 |
Why?
|
| Hematologic Diseases | 1 | 2019 | 62 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 405 | 0.040 |
Why?
|
| Standard of Care | 1 | 2019 | 72 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 786 | 0.040 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2021 | 213 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2018 | 106 | 0.040 |
Why?
|
| Arginine | 1 | 2019 | 271 | 0.040 |
Why?
|
| Leukocytes | 1 | 2019 | 311 | 0.030 |
Why?
|
| P-Selectin | 1 | 2017 | 28 | 0.030 |
Why?
|
| Rabbits | 1 | 2019 | 794 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 2017 | 28 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 597 | 0.030 |
Why?
|
| Cell Communication | 1 | 2019 | 315 | 0.030 |
Why?
|
| Complement C5a | 1 | 2017 | 71 | 0.030 |
Why?
|
| Complement C3a | 1 | 2017 | 42 | 0.030 |
Why?
|
| Exocytosis | 1 | 2017 | 89 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 314 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 554 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 239 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 739 | 0.030 |
Why?
|
| Temperature | 1 | 2019 | 679 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2020 | 778 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2020 | 911 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 1972 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2019 | 429 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 628 | 0.030 |
Why?
|
| Neutrophils | 1 | 2020 | 1238 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2847 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2020 | 1096 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2019 | 915 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 2057 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 2085 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2828 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 4193 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 5757 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 17787 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 15657 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 23961 | 0.010 |
Why?
|
| Neoplasms | 1 | 2019 | 2671 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 13209 | 0.010 |
Why?
|